Table 1 Clinicopathological characteristics of patients of T1, T2a, T2b and T3 group
From: Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
Characteristics | T1 group (n = 1117) | T2a group (n = 1019) | T2b group (n = 869) | T3 group (n = 1081) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R-CT | ARH | NACT | P | R-CT | ARH | NACT | P | R-CT | ARH | NACT | P | R-CT | ARH | NACT | P | |
(n) % | (n) % | (n) % | (n) % | (n) % | (n) % | (n) % | (n) % | (n) % | (n) % | (n) % | (n) % | |||||
Age(years) | 53.83 ± 12.70 | 46.78 ± 9.04 | 44.72 ± 8.25 |  < 0.001 | 55.01 ± 10.48 | 49.98 ± 9.54 | 47.62 ± 8.34 |  < 0.001 | 54.44 ± 10.78 | 48.93 ± 9.81 | 47.55 ± 8.41 |  < 0.001 | 54.64 ± 10.8 | 54.9 ± 9.01 | 48.33 ± 9.02 | 0.048 |
Histological type |  |  |  | 0.082 |  |  |  | 0.141 |  |  |  |  < 0.001 |  |  |  |  < 0.001 |
Squamous cell carcinoma | 57(98.3) | 727(86.8) | 192(86.9) | Â | 148(94.3) | 552(90.8) | 226(89.0) | Â | 624(96.7) | 67(91.8) | 130(86.1) | Â | 1014(96.3%) | 9(90.0%) | 15(83.3%) | Â |
Adenocarcinoma | 0(0) | 76(9.1) | 23(10.4) | Â | 3(1.9) | 40(6.6) | 20(7.9) | Â | 17(2.6) | 6(8.2) | 13(8.6) | Â | 30(2.8%) | 1(10%) | 1(5.6%) | Â |
Adenosquamous cell carcinoma | 1(1.7) | 35(4.2) | 6(2.7) | Â | 6(3.8) | 16(2.6) | 8(3.1) | Â | 4(0.6) | 0(0) | 8(5.3) | Â | 9(0.9%) | 0(0%) | 2(11.1%) | Â |